Drawing for WEIXINKANG WXK

USPTO serial 87297032

WEIXINKANG WXK

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LINDEMYER, ANKHI MUKHERJEA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WEIXINKANG WXK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Simor L. Moskowitz

Simor L. Moskowitz WESTERMAN, HATTORI, DANIELS & ADRIAN, LLP8500 Leesburg PikeSUITE 7500Tysons, VA 22182

Goods and services

ClassDescriptionStatusFirst use
005vitamin preparations; electrolytes replacement solutions; pharmaceutical preparations of trace elements for human and animal use; medicines for the treatment of liver disease; antibiotics; medicines for human purposes for the treatment of digestive system disease, liver disease, anemia, cardiovascular disease, tumors, and used in the field of parenteral nutrition and anticoagulation; chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical purposes used in the treatment of digestive system disease, liver disease, anemia, cardiovascular disease, tumors, and used in the field of parenteral nutrition and anticoagulation; drugs for medical purposes, namely, antivirals; dietetic substances adapted for medical use, namely, dietetic foods adapted for medical purposes; depurative for the body; pesticides; disinfectant wipes, namely, disposable sanitizing wipes; medical dressings; teeth filling material; diapers for petsACTIVE—
010medical apparatus and instruments for use in surgery; diagnostic apparatus for medical purposes, namely, detecting digestive system disease, liver disease, anemia, cardiovascular disease, tumors, and used in the field of parenteral nutrition and anticoagulation; dental apparatus and instruments, namely, dental burs; physiotherapy apparatus, namely, electric heating pads for medical purposes; Auxiliary apparatus, namely, instruments and articles for medical purposes, namely, gastroscopes, blood testing apparatus, stethoscopes, hypodermic syringes, forceps, mirrors for surgeons, arterial blood pressure apparatus used for detecting and treating digestive system disease, liver disease, anemia, cardiovascular disease, tumors, parenteral nutrition, and anticoagulation; feeding bottles; surgical implants comprised of artificial materials; suture materialsACTIVE—
035advertisement and publicity for medicines; business management assistance for medicines and medical supplies; sales promotion for medicines and medical supplies; retail or wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical suppliesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 9, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 9, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 17, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2021EX5GSOU EXTENSION 5 GRANTED—
Sep 16, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 10, 2021EXT5SOU EXTENSION 5 FILED—
Sep 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 6, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 4, 2021EX4GSOU EXTENSION 4 GRANTED—
Mar 4, 2021EXT4SOU EXTENSION 4 FILED—
Mar 4, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 3, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 1, 2020EX3GSOU EXTENSION 3 GRANTED—
Sep 1, 2020EXT3SOU EXTENSION 3 FILED—
Sep 1, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2020DOCKASSIGNED TO EXAMINER—
Mar 13, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 11, 2020EX2GSOU EXTENSION 2 GRANTED—
Mar 11, 2020EXT2SOU EXTENSION 2 FILED—
Mar 11, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 13, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 11, 2019EX1GSOU EXTENSION 1 GRANTED—
Sep 11, 2019EXT1SOU EXTENSION 1 FILED—
Sep 11, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 26, 2018ALIEASSIGNED TO LIE—
Dec 7, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 4, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 4, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 4, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 4, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 7, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 7, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 7, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 7, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 7, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 25, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 25, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 25, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 25, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 4, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2017DOCKASSIGNED TO EXAMINER—
Jan 19, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 18, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance